HUDDINGE, Sweden, Feb. 8, 2024 /PRNewswire/ — XNK Therapeutics AB (“XNK”) today announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14. XNK’s presentation starts at 10:45 CET. The event will be broadcasted live…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.